EMEA-000599-PIP01-09-M07
Key facts
| Invented name |
Aflunov
|
| Active substance |
Influenza virus surface antigens - A/turkey/Turkey/1/05 (H5N1)
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0189/2020
|
| PIP number |
EMEA-000599-PIP01-09-M07
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Prevention of influenza
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Seqirus S.r.l.
E-mail: pip.seq@seqirus.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|